v3.22.2.2
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Schedule of Income Tax Provision Benefit

The total provision (benefit) for income taxes is comprised of the following:

 

     March 31, 2022     December 31, 2021 
   March 31, 2022   December 31, 2021 
Current expense  $-   $- 
Deferred expense   (42,475)   (28,466)
Change in valuation allowance   (42,475)   (28,466)
Total income tax expense (benefit)  $-   $- 
Schedule of Deferred Tax Assets And Liabilities Table

The net deferred tax assets and liabilities in the accompanying balance sheets included the following components:

 

     March 31, 2022     December 31,2021 
   March 31, 2022   December 31,2021 
Deferred tax assets          
Start-up costs  $43,032   $10,793 
Net operating loss   27,909    17,673 
Total Deferred tax assets   70,941    28,466 
Deferred tax liabilities   -    - 
Valuation allowance for deferred tax assets   (70,941)   (28,466)
Net deferred tax assets  $-   $- 
Schedule of Effective Income Tax Rate Reconciliation

A reconciliation of the statutory federal income tax rate (benefit) to the Company’s effective tax rate is as follows:

 

     March 31, 2022     December 31, 2021 
   March 31, 2022   December 31, 2021 
Statutory federal income tax rate   21.00%   21.00%
Transaction costs warrants   0.00%   (0.1)%
Change in FV warrants   6.4%   2.9%
State taxes, net of federal tax benefit   0.00%   0.00%
Valuation allowance   (27.4)%   (23.8)%
Income tax provision expense   0%   0%
Schedule of Subject To Possible Redemption

At March 31, 2022, and December 31, 2021, the common stock subject to possible redemption reflected in the balance sheet is reconciled in the following table:

 

      
Gross proceeds  $115,000,000 
Less:     
Proceeds allocated to Public Warrants   (10,465,000)
Common stock issuance costs   (6,236,933)
Plus: Accretion of carrying value to redemption value   18,426,933 
Common stock subject to possible redemption  $116,725,000 
Schedule of Net Loss Basic and Diluted Per Share

 

Basic and diluted net loss per share:  Redeemable   Non-redeemable 
For the three months ended March 31, 2022  Common Stock 
Basic and diluted net loss per share:  Redeemable   Non-redeemable 
NUMERATOR          
Allocation of net loss  $(119,189)  $(35,705)
DENOMINATOR          
Weighted Average Shares Outstanding including common stock subject to redemption   11,500,000    3,445,000 
EPS          
Basic and diluted net loss per share  $(0.01)  $(0.01)